Grants and Contributions:
Title:
ARP - Imaging optimization of pharmaceutical molecules, without the use of ionizing agents or heavy metals, for studies in preclinical phases
Agreement Number:
929252
Agreement Value:
$50,000.00
Agreement Date:
Jun 10, 2019 - Mar 31, 2020
Description:
Development of molecular imaging methods to locate drugs in a living body, without the addition of ionizing radioactive (agents) or heavy metals, allowing us for the first time, to marry therapy and diagnosis (pure theranostic) in only one medical condition.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Bromont, Quebec, CA J2L 2J4
Reference Number:
172-2019-2020-Q1-929252
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
771106523
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 81 days.
Amendment Date
Dec 9, 2019
Recipient's Legal Name:
Imagerie Fluoid inc.
Federal Riding Name:
Brome--Missisquoi
Federal Riding Number:
24016
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54169
Amendments: